Verana Health and COTA merge to accelerate research-ready oncology real-world evidence

SU2C + CRUK secure $3M for gastric cancer research

Stand Up To Cancer and Cancer Research UK secured $3 million in new support for a “dream team” focused on stopping gastric cancer in its earliest stages.

January 16, 2026

Vol.52 No.02

Cancer Policy

Journal retracts decades-old study that determined glyphosate, widely used herbicide, as safe

Regulatory Toxicology and Pharmacology has retracted a literature review published in 2000 that concluded that glyphosate, a common herbicide used in agriculture and found in products such as Roundup, “does not pose a health risk to humans.”

American Center for Cures and BlueCloudX collaborate to accelerate cures, modernize healthcare and clinical research

American Center for Cures and BlueCloudX announced a strategic collaboration aimed at accelerating the development of cures for major diseases while dramatically reducing the time, cost, and complexity of clinical research.

January 09, 2026

Vol.52 No.1

Drugs & Targets

Niowave expands global agreement with AstraZeneca for 10-year actinium-225 supply

Niowave Inc. and AstraZeneca are expanding their existing supply agreement to a 10-year commitment to deliver actinium-225, following AstraZeneca’s decision to exercise its option to increase capacity.

January 09, 2026

Vol.52 No.1

Cancer Policy

Dana-Farber to pay $15M to U.S. government in research fraud settlement

Dana-Farber Cancer Institute has agreed to pay $15 million to the U.S. government in a settlement to resolve allegations that, between 2014 and 2024, Dana-Farber violated the False Claims Act by “using fraudulent images in grant applications and research articles to induce the NIH to pay millions of dollars to support research at Dana-Farber.”

Reimagine Care, Tampa General collaborate to improve cancer care delivery

Reimagine Care and Tampa General Hospital Cancer Institute are teaming up to expand access, increase clinical capacity, and improve cancer care delivery across the Tampa Bay region.

December 19, 2025

Vol.51 No.46

Verana Health and COTA merge to accelerate research-ready oncology real-world evidence

YOU MAY BE INTERESTED IN

SU2C + CRUK secure $3M for gastric cancer research

Journal retracts decades-old study that determined glyphosate, widely used herbicide, as safe

American Center for Cures and BlueCloudX collaborate to accelerate cures, modernize healthcare and clinical research

Niowave expands global agreement with AstraZeneca for 10-year actinium-225 supply

Dana-Farber to pay $15M to U.S. government in research fraud settlement

Reimagine Care, Tampa General collaborate to improve cancer care delivery

Renew today!

Subscriber content

Never miss an issue!

Login